Skip to main content

Freya Biosciences

Boston, United States

Freya Biosciences is a clinical-stage women's health company pioneering a new class of microbial immunotherapies.

$11.8M raised
Nov 2024
Series A

Top Investors

Bill & Melinda Gates FoundationSofinnova PartnersOMX VenturesAngelini VenturesIndaco Venture Partners

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Freya Biosciences

How much funding has Freya Biosciences raised?
Freya Biosciences has raised $11.8M in total funding. The most recent round was Series A. The last funding was announced in November 2024.
Who are Freya Biosciences's investors?
Freya Biosciences's investors include Bill & Melinda Gates Foundation, Sofinnova Partners, OMX Ventures, Angelini Ventures, Indaco Venture Partners.
Where is Freya Biosciences headquartered?
Freya Biosciences is headquartered in Boston, United States.
What does Freya Biosciences do?
Freya Biosciences is a clinical-stage women's health company pioneering a new class of microbial immunotherapies.
What stage is Freya Biosciences at?
Freya Biosciences is at the Series A stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Freya Biosciences — Funding & Investors." VCBacked, November 19, 2024, https://www.vcbacked.co/company/freya-biosciences. Accessed June 13, 2026.
APA
VCBacked. (2024). Freya Biosciences — Funding & Investors. Retrieved June 13, 2026, from https://www.vcbacked.co/company/freya-biosciences
Wikipedia (cite web)
{{cite web |title=Freya Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/freya-biosciences |website=VCBacked |access-date=June 13, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .